IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
High serum levels of IL-6 correlate with poor outcome in breast cancer patients. However, no data are available on the relationship between IL-6 and mammary stem/progenitor cells, which may fuel the genesis of breast cancer in vivo. Herein, we address this issue in the MCF-7 breast cancer cell line and in primary human mammospheres (MS), multicellular structures enriched in stem/progenitor cells of the mammary gland. MS from node invasive breast carcinoma tissues expressed IL-6 mRNA at higher levels than did MS from matched non-neoplastic mammary glands. In addition, IL-6 mRNA was detected only in basal-like breast carcinoma tissues, an aggressive breast carcinoma variant showing stem cell features. IL-6 treatment triggered Notch-3-dependent upregulation of the Notch ligand Jagged-1 and promotion of MS and MCF-7-derived spheroid growth. Moreover, IL-6 induced Notch-3-dependent upregulation of the carbonic anhydrase IX gene and promoted a hypoxia-resistant/invasive phenotype in MCF-7 cells and MS. Finally, autocrine IL-6 signaling relied upon Notch-3 activity to sustain the aggressive features of MCF-7-derived hypoxia-selected cells. In conclusion, these data support the hypothesis that IL-6 induces malignant features in Notch-3-expressing stem/progenitor cells from human ductal breast carcinoma and normal mammary gland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is an MSC-secreted inflammatory cytokine displaying pro-survival, pro-growth and pro-angiogenic activities [11], which has been implicated in tumor progression of various cancers including breast cancer [113, 114].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Research works printed but not linked: 4
- Zhang, 1999, Anticancer Res., 19, 1427
- Sehgal, 1991, EXS., 59, 178
- Conze, 2001, Cancer Res., 61, 8851
- Trikha, 2003, Clin. Cancer Res., 9, 4653
Cited by
Items 501–600 of 839
Hou, L., Xie, S., Li, G., Xiong, B., Yanchun, G., Zhao, X., Hu, J., Deng, S., & Jiang, J. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13042 · Cited by 24
Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells
Poczobutt, J. M., Tentler, J. J., Lu, X. J. D., Schedin, P. S., & Gutierrez‐Hartmann, A. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-373 · Cited by 24
Yang, Y., Ma, X., Li, Y., Jin, L., & Zhou, X. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03831-8 · Cited by 23
Si, J., Zhang, P., Tian, D., Wang, X., Ma, Y., Zhang, J., Wang, L., & Yang, Y. (2017) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-1094-z · Cited by 23
Buczek, E., Denslow, A. J., Mateuszuk, Ł., Proniewski, B., Wójcik, T., Sitek, B., Fedorowicz, A., Jasztal, A., Kuś, E., Chmura-Skirliñska, A., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4445-z · Cited by 23
Shash, L. S., Ibrahim, R. A., & Elgohary, S. A. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000940 · Cited by 23
Down-regulation of the Fetal Stem Cell Factor SOX17 by H33342
Christgen, M., Geffers, R., Ballmaier, M., Christgen, H., Poczkaj, J., Krech, T., Kreipe, H. H., & Lehmann, U. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.082941 · Cited by 23
Top Notch cancer stem cells by paracrine NF-κB signaling in breast cancer
Zhang, W., & Grivennikov, S. I. (2013) · Breast Cancer Research · doi:10.1186/bcr3565 · Cited by 23
Mezquita, B., Mezquita, P., Pau, M., Mezquita, J., & Mezquita, C. (2014) · Cells · doi:10.3390/cells3010092 · Cited by 22
Gupta, N., Goswami, B., & Mittal, P. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.11.007 · Cited by 22
Stem cell therapy: A paradigm shift in breast cancer treatment
Khan, S. M., Suryavanshi, M., Kaur, J., Nayak, D., Khurana, A. K., Manchanda, R. K., Tandon, C., & Tandon, S. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i7.841 · Cited by 22
Insights into the Regulation of Tumor Dormancy by Angiogenesis in Experimental Tumors
Indraccolo, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1445-2_3 · Cited by 22
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells
Storci, G., Bertoni, S., Carolis, S. D., Papi, A., Nati, M., Ceccarelli, C., Pirazzini, C., Garagnani, P., Ferrarini, A., Buson, G., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.020 · Cited by 22
Self-citationSAU, A. C., Cabrita, M. A., & Pratt, M. A. C. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0225 · Cited by 21
MLL1 regulates cytokine-driven cell migration and metastasis
Nair, P. R., Danilova, L., Gómez‐de‐Mariscal, E., Kim, D., Fan, R., Muñoz‐Barrutia, A., Fertig, E. J., & Wirtz, D. (2024) · Science Advances · doi:10.1126/sciadv.adk0785 · Cited by 21
Taniguchi, Y., Kurokawa, Y., Hagi, T., Takahashi, T., Miyazaki, Y., Tanaka, K., Makino, T., Yamasaki, M., Nakajima, K., Mori, M., et al. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07585-4 · Cited by 21
Kengelbach‐Weigand, A., Tasbihi, K., Strissel, P. L., Schmid, R., Marques, J. M., Beier, J. P., Beckmann, M. W., Strick, R., Horch, R. E., & Boos, A. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-47224-2 · Cited by 21
Lee, H., Choi, Y., Kim, S. H., Zhong, X., Kim, W., Park, J. S., Saeidi, S., Han, B. W., Kim, N., Lee, H. S., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002392r · Cited by 21
Joshi, N. N., Kannan, S., Kotian, N., Bhat, S., Kale, M., & Hake, S. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.06.018 · Cited by 21
Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells
Usami, S., Motoyama, S., Koyota, S., Wang, J., Hayashi-Shibuya, K., Maruyama, K., Takahashi, N., Saito, H., Minamiya, Y., Takasawa, S., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.129 · Cited by 21
Expression of Stanniocalcin 1 in Thyroid Side Population Cells and Thyroid Cancer Cells
Hayase, S., Sasaki, Y., Matsubara, T., Seo, D., Miyakoshi, M., Murata, T., Ozaki, T., Kakudo, K., Kumamoto, K., Ylaya, K., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0464 · Cited by 21
Platonova, N., Parravicini, C., Sensi, C., Paoli, A., Colombo, M., Neri, A., Eberini, I., & Chiaramonte, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182640 · Cited by 21
Matsuno, Y., Kiwamoto, T., Morishima, Y., Ishii, Y., Hizawa, N., & Hogaboam, C. M. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.09.001 · Cited by 21
Xie, H., Wei, L., Ruan, G., Zhang, H., & Shi, H. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s484962 · Cited by 20
Bullock, E., Rozyczko, A., Shabbir, S., Tsoupi, I., Young, A. I. J., Trávníčková, J., Gómez-Cuadrado, L., Mabruk, Z., Carrasco, G., Morrow, E. S., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02074-x · Cited by 20
Villéger, R., Chulkina, M., Mifflin, R. C., Markov, N. S., Trieu, J. A., Sinha, M., Johnson, P. R., Saada, J. I., Adegboyega, P. A., Luxon, B. A., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02066-0 · Cited by 21
Liao, Y., Luo, Z., Liu, Y., Xue, W., He, S., Chen, X., Ren, H., Yang, X. M., Zhu, D., Su, Z., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116133 · Cited by 20
MyD88 signaling pathways: role in breast cancer
Zheng, H., Wu, X., Guo, L., & Liu, J. H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1336696 · Cited by 20
Engraftment Potential of Spheroid-Forming Hepatic Endoderm Derived from Human Embryonic Stem Cells
Kim, S. E., An, S. Y., Woo, D., Han, J., Kim, J. H., Jang, Y. J., Son, J. S., 양현원, Cheon, Y. P., & Kim, J. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0401 · Cited by 20
Bissoli, I., & Muscari, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109927 · Cited by 20
Not Only Immune Escape—The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis
Kwiatkowska, I., Hermanowicz, J. M., Przybyszewska-Podstawka, A., & Pawlak, D. (2021) · Cancers · doi:10.3390/cancers13112667 · Cited by 20
Maruyama, S., Okamura, A., Kanie, Y., Sakamoto, K., Fujiwara, D., Kanamori, J., Imamura, Y., Kumagai, K., & Watanabe, M. (2022) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-022-02508-6 · Cited by 20
Bel’skaya, L. V., Loginova, A. I., & Sarf, E. A. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100319 · Cited by 20
The Role of the Transcriptional Regulation of Stromal Cells in Chronic Inflammation
Valín, Á., & Pablos, J. L. (2015) · Biomolecules · doi:10.3390/biom5042723 · Cited by 21
HPI/AMF inhibition halts the development of the aggressive phenotype of breast cancer stem cells
Gallardo‐Pérez, J. C., de Guevara, A. A.-L., Marín‐Hernández, Á., Moreno‐Sánchez, R., & Rodríguez‐Enríquez, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.06.015 · Cited by 20
Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review
Zarezadeh, S. M., Sharafi, A. M., Erabi, G., Tabashiri, A., Teymouri, N., Mehrabi, H., Golzan, S. A., Faridzadeh, A., Abdollahifar, Z., Sami, N., et al. (2023) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892818666230803100554 · Cited by 19
Schillace, R. V., Skinner, A. M., Pommier, R. F., O’Neill, S., Muller, P. J., Naik, A. M., Hansen, J. E., & Pommier, S. J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-733 · Cited by 19
CD200fc enhances anti-tumoral immune response and inhibits visceral metastasis of breast carcinoma
Erin, N., Tanrιöver, G., Curry, A., Akman, M., Duymuş, Ö., & Gorczynski, R. (2018) · Oncotarget · doi:10.18632/oncotarget.24931 · Cited by 19
Wouters, J., Stas, M., Govaere, O., den Eynde, K. V., Vankelecom, H. E. J., & van den Oord, J. J. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.01004.x · Cited by 19
Zhang, F., Chen, M., Hu, S., Pang, K., & Jin, W. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-18315-4 · Cited by 19
Immunosenescence: Molecular Mechanisms, Diseases, and Therapeutic Innovations
Gong, N., Pan, X., Deng, Y., Che, J., Bao, J., Wang, M., Xu, C., Liu, X., & Shi, Y. (2025) · MedComm · doi:10.1002/mco2.70515 · Cited by 18
Cui, H., Li, X., Que, J., Li, S., Shi, X., & Yuan, T. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131186 · Cited by 18
Osińska, E., Wicik, Z., Godlewski, M. M., Pawłowski, K., Majewska, A., Mucha, J., Gajewska, M., & Motyl, T. (2014) · Journal of Applied Genetics · doi:10.1007/s13353-014-0213-1 · Cited by 18
Intracellular signals of lung cancer cells as possible therapeutic targets
Tanaka, K., Kumano, K., & Ueno, H. (2015) · Cancer Science · doi:10.1111/cas.12643 · Cited by 18
Kiyomi, A., Makita, M., Ozeki, T., Li, N., Satomura, A., Tanaka, S., Onda, K., Sugiyama, K., Iwase, T., & Hirano, T. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.06.004 · Cited by 18
Shi, Y., Yu, P.-W., Zeng, D.-Z., Qian, F., Lei, X., Zhao, Y., Tang, B., Hao, Y., Luo, H.-X., Chen, J., et al. (2014) · FEBS Journal · doi:10.1111/febs.12923 · Cited by 18
Trindade‐da‐Silva, C. A., Reis, C. F., Vecchi, L., Napimoga, M. H., Sperandio, M., Colombo, B. F. M., Alves, P. T., Ward, L. S., Ueira‐Vieira, C., & Goulart, L. R. (2016) · PPAR Research · doi:10.1155/2016/4106297 · Cited by 18
Aberrant DNA methylation profile in cholangiocarcinoma
Huang, L. (2010) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v1.i2.23 · Cited by 18
Autocrine IL-6 regulates GRO-α production in thymic epithelial cells
Tseng, Y., Wu, M., Yang, H.-C., Wang, C., & Lin, C. (2010) · Cytokine · doi:10.1016/j.cyto.2010.05.002 · Cited by 18
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
Zender, S., Nickeleit, I., Wüestefeld, T., Sörensen, I., Dauch, D., Bozko, P. M., El-Khatib, M., Geffers, R., Bektas, H., Manns, M. P., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.005 · Cited by 18
Shaping of the Tumor Microenvironment by Notch Signaling
Meurette, O. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35582-1_1 · Cited by 17
Ahmed, H. H., Aglan, H. A., Elsayed, G. H., Hafez, H. G., & Eskander, E. F. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00499 · Cited by 17
Sater, A. H. A., Bouferraa, Y., Amhaz, G., Haibe, Y., Lakkiss, A. E., & Shamseddine, A. I. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.804983 · Cited by 17
Hepatocellular carcinoma: from hepatocyte to liver cancer stem cell
Karakasiliοtis, I., & Mavromara, P. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00154 · Cited by 17
Characteristics of carbonic anhydrase 9 expressing cells in human intestinal crypt base
Takahashi, H., Suzuki, Y., Nishimura, J., Haraguchi, N., Ohtsuka, M., Miyazaki, S., Uemura, M., Hata, T., Takemasa, I., Mizushima, T., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3260 · Cited by 17
Pilskog, M., Bostad, L. H., Edelmann, R. J., Akslen, L. A., Beisland, C., & Straume, O. (2018) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.96 · Cited by 17
Liu, X., Cao, X., Liu, C., Cao, Y., Zhao, Q., Tan, X., Li, X., Xu, X., Yu, E., & Wang, H. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.36916 · Cited by 17
Stojanovska, V., Shah, A., Woidacki, K., Fischer, F., Bauer, M., Lindquist, J. A., Mertens, P. R., & Zenclussen, A. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137226 · Cited by 16
Zou, Z., Luo, T., Wang, X., Wang, B., & Li, Q. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31278 · Cited by 16
Liu, C., Su, J., Ni, M.-H., Tseng, L., Chu, P., Wang, D., Tai, W., Kao, Y.-P., Hung, M., Shiau, C., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3000-0 · Cited by 16
Carbonic Anhydrase 9 mRNA/microRNA34a Interplay in Hypoxic Human Mammospheres
Carolis, S. D., Bertoni, S., Nati, M., D'Anello, L., Papi, A., Tesei, A., Cricca, M., & Bonafè, M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25245 · Cited by 16
Self-citationMolecular Mechanisms Underlying Breast Cancer and Role of Plant Products in Targeted Therapy
Singhal, S., Singh, M., Singh, R., Tiwari, V., & Bajpai, S. (2021) · Discovery and Development of Anti-Breast Cancer Agents from Natural Products · doi:10.1016/b978-0-12-821277-6.00011-8 · Cited by 14
Yoshida, A., Kitajima, S., Li, F., Cheng, C., Takegami, Y., Kohno, S., Wan, Y., Hayashi, N., Muranaka, H., Nishimoto, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14681 · Cited by 16
Rajayi, H., Tavasolian, P., Rezalotfi, A., & Ebrahimi, M. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1669593 · Cited by 16
CCDC68 Upregulation by IL-6 Promotes Endometrial Carcinoma Progression
Li, X., Li, H., Pei, X., Zhou, Y., & Wei, Z. (2021) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0193 · Cited by 15
Cancer Cachexia and breast cancer stem cell signalling – A crosstalk of signalling molecules
Shivnani, P., Shekhawat, S., & Prajapati, A. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110847 · Cited by 15
Elsarraj, H. S., Valdez, K. E., Hong, Y., Grimm, S. L., Ricci, L. R., Fan, F., Tawfik, O. W., May, L., Cusick, T., Inciardi, M. F., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2794 · Cited by 15
The Notch-3 receptor: A molecular switch to tumorigenesis?
Inder, M. S., O’Rourke, S. A., McDermott, N., Manecksha, R. P., Finn, S. P., Lynch, T. H., & Marignol, L. H. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.08.011 · Cited by 15
Lunatic Fringe and p53 Cooperatively Suppress Mesenchymal Stem-Like Breast Cancer
Chung, W.-C., Zhang, S., Challagundla, L., Zhou, Y., & Xu, K. (2017) · Neoplasia · doi:10.1016/j.neo.2017.08.006 · Cited by 15
Morrow, R. J., Allam, A. H., Yeo, B. J., Deb, S., Murone, C., Lim, E., Johnstone, C. N., & Ernst, M. (2022) · Cancers · doi:10.3390/cancers14092292 · Cited by 15
Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity
Blander, H. D., Tonon, L., Fauvet, F., Pommier, R. M., Lamblot, C., Benhassoun, R., Angileri, F., Gibert, B., Rodriguez, R., Ouzounova, M., et al. (2024) · Science Advances · doi:10.1126/sciadv.adi1736 · Cited by 14
Ghosh, S., Elankumaran, S., & Puri, I. K. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00739.x · Cited by 14
Erin, N., Dilmaç, S., Curry, A., Duymuş, Ö., Tanrιöver, G., Prodeus, A., Gariépy, J., & Gorczynski, R. M. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02444-3 · Cited by 14
HMGA1a Recognition Candidate DNA Sequences in Humans
Manabe, T., Katayama, T., & Tohyama, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008004 · Cited by 14
Gharbaran, R., Park, J., Kim, C., Goy, A. H., & Suh, K. S. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.09.004 · Cited by 13
Interleukin-6 and the Gut Microbiota Influence Melanoma Progression in Obese Mice
Pereira, F. V., de Melo, A. C. L., da Silva, M. B., de Melo, F. M., Terra, F. F., Castro, I. A., Perandini, L. A., Miyagi, M. T., Sato, F. T., Origassa, C. S. T., et al. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1764982 · Cited by 13
Cellular and Molecular Mechanisms of Tumor Promotion
Rundhaug, J. E., & Fischer, S. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01416-0 · Cited by 13
Acronyms (2012) · Legal Abbreviations and Acronyms · Cited by 13
Cancer stem cells: Masters of all traits
Leck, L. Y. W., El-Aziz, Y. S. A., McKelvey, K. J., Park, K. C., Sahni, S., Lane, D. J. R., Skoda, J., & Jansson, P. J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167549 · Cited by 12
Ware, M. B., Zaidi, M. Y., Yang, J., Turgeon, M. K., Krasinskas, A. M., Mace, T. A., Keenan, K. E., Farren, M. R., Ruggieri, A. N., Li, Y., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-1018-0 · Cited by 12
Chen, C., Wang, Z., Liao, Z., Zhang, Y., Lei, W., & Shui, X. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13134 · Cited by 12
Motoyama, S., Nakatsu, T., Miura, M., Hinai, Y., Minamiya, Y., & Ogawa, J. (2012) · Digestive Surgery · doi:10.1159/000336952 · Cited by 12
Breast Cancer-Initiating Cells: Insights into Novel Treatment Strategies
Santilli, G., Binda, M., Zaffaroni, N., & Daidone, M. G. (2011) · Cancers · doi:10.3390/cancers3011405 · Cited by 12
Aging and lung diseases: Unraveling mechanisms and therapeutic targets
Zhou, Y., Chen, G., Li, X., Li, X., Lin, Z., Liu, L., Pu, D., Chen, J., Chen, Y., Lin, Z., et al. (2025) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2025.11.005 · Cited by 11
Anti-tumour effect of tocilizumab for osteosarcoma cell lines
Hagi, T., Nakamura, T., Kita, K., Iino, T., Asanuma, K., & Sudo, A. (2020) · Bone and Joint Research · doi:10.1302/2046-3758.911.bjr-2020-0123.r1 · Cited by 11
Lučić, I., Kurtović, M., Mlinarić, M., Piteša, N., Gašparović, A. Č., Sabol, M., & Milković, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310683 · Cited by 11
Notch ligands are biomarkers of anti-TNF response in RA patients
Zack, S. R., Meyer, A., Zanotti, B., Volin, M. V., Deen, S., Satoeya, N., Sweiss, N., Lewis, M., Pitzalis, C., Kitajewski, J., et al. (2023) · Angiogenesis · doi:10.1007/s10456-023-09897-2 · Cited by 11
Berger, K., Persson, E., Gregersson, P., Ruiz‐Martínez, S., Jonasson, E., Ståhlberg, A., Rhost, S., & Landberg, G. (2023) · Cancers · doi:10.3390/cancers15245757 · Cited by 11
Globally profiling sialylation status of macrophages upon statin treatment
Wang, D., Nie, H., Ozhegov, E., Wang, L., Zhou, A., Li, Y., & Sun, X. (2015) · Glycobiology · doi:10.1093/glycob/cwv038 · Cited by 11
Ramdass, B., Duggal, R., Minev, B., Chowdhary, A. S., & Koka, P. S. (2013) · PubMed · Cited by 11
Differential expression of cytokines and receptor expression during anoxic growth
Plotkin, B. J., Sigar, I. M., Swartzendruber, J. A., Kaminski, A., & Davis, J. W. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3520-5 · Cited by 11
The Interplay of Aging and Cancer: Mechanisms, Implications, and Therapeutic Strategies
Wang, L., Luo, Y., Chen, X., Wang, Y., & Zhang, Y. (2025) · MedComm – Oncology · doi:10.1002/mog2.70041 · Cited by 10
Yuzhalin, A. E., & Kutikhin, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801121-8.00005-1 · Cited by 10
Treating Metastatic Brain Cancers With Stem Cells
Sadanandan, N., Shear, A., Brooks, B., Saft, M., Cabantan, D. A. G., Kingsbury, C., Zhang, H., Anthony, S., Wang, Z.-J., Salazar, F. E., et al. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.749716 · Cited by 10
Ambrose, J. M., Veeraraghavan, V. P., Vennila, R., Rupert, S., Sathyanesan, J., Meenakshisundaram, R., Selvaraj, S., Malayaperumal, S., Kullappan, M., Dorairaj, S., et al. (2022) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-022-00152-1 · Cited by 10
Wang, L., Choi, H. S., Lee, B., Choi, J. H., Jang, Y., & Seo, J.-W. (2021) · Antioxidants · doi:10.3390/antiox10030457 · Cited by 10
Wu, M., Cao, Y. L., Liu, Y., Ma, L., & Yang, X. R. (2016) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000429 · Cited by 10
Grudzien, P., Strack, P. R., Golde, T. E., Miele, L., & Foreman, K. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-106 · Cited by 10
Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma
Zhang, Y., & Gu, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.889844 · Cited by 9
Kim, S., Kim, H., Jeong, Y., You, D., Yoon, S. Y., Lo, E., Nam, S. J., Lee, J. E., & Kim, S. W. (2023) · Biomedicines · doi:10.3390/biomedicines11030675 · Cited by 9
Metadata
- Authors
- Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., Chieco, P., & Bonafè, M.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- University of Bologna (IT)
- Corresponding author
- Bonafè, Massimiliano
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-12-03
- Volume
- 117
- Issue
- 12
- Pages
- 3988-4002
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2096439
- OpenAlex
- W2114817620
- Cited by
- 779
- References
- 61
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 21 · 2023: 29 · 2022: 27 · 2021: 27 · 2020: 55 · 2019: 40 · 2018: 55 · 2017: 52 · 2016: 45 · 2015: 64 · 2014: 71 · 2013: 70 · 2012: 53
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Fondazione Cassa di Risparmio in Bologna
- Università di Bologna
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- interleukin-6, mammospheres, mammary stem/progenitor cells, breast ductal carcinoma, Notch3, Jagged1, carbonic anhydrase IX, hypoxia tolerance, breast cancer invasion, basal-like breast cancer, MCF-7 cells, autocrine signaling, tumor microenvironment
- MeSH terms
- Carbonic Anhydrase IX, Receptor, Notch3, Serrate-Jagged Proteins, Jagged-1 Protein, Antigens, Neoplasm, Breast Neoplasms, Calcium-Binding Proteins, Carbonic Anhydrases, Female, Humans, Membrane Proteins, Neoplasm Invasiveness, Neoplasm Proteins, RNA, Messenger, RNA, Neoplasm, Stem Cells, Cell Hypoxia, Interleukin-6, Up-Regulation, Gene Expression Regulation, Neoplastic, Spheroids, Cellular, Autocrine Communication, Intercellular Signaling Peptides and Proteins, Mammary Glands, Human, Carcinoma, Ductal, Cell Line, Tumor, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.